Stock Analysis·← Pickers

PRVA

Privia Health Group, Inc.

Privia Health Group, Inc. (PRVA) is currently in an uptrend, trading above both the 50-day and 200-day moving averages. RSI is at 78.6 (overbought), with 3/3 trend checks passing.

Price
$28.10
2026-07-16
Trend score
3/3
Uptrend
RSI (14)
78.6
Overbought
Price above MA50Price above MA200MA50 above MA200
Change stock
Search another ticker to view its stock analysis page.
Chart View

PRVA with MA50 and MA200

28.1025.7923.4821.1718.8607/3110/2401/2204/1707/15
PRVA2025-07-312026-07-15
PriceMA50MA200
Technical Indicators

Key levels & signals

MA50
$23.95+17.31% vs price
MA200
$23.59+19.13% vs price
RSI (14)
78.6Overbought zone
MACD Signal
BullishMomentum above signal
Macro Support
$23.04–$23.7215.6% below price · 2 touches
Support Quality
2 touches1.0× zone volume
Chart Summary
Trend summary for PRVA

Privia Health Group, Inc. (PRVA) is still trading in a constructive trend overall. The latest available price is $28.10, and 3 of 3 core trend checks are currently passing. Price is trading above the 50-day moving average by 17.3% and above the 200-day moving average by 19.1%.

Momentum and stretch context

PRVA currently has an RSI reading of 78.6, which points to very strong short-term momentum but also a fairly extended setup. Stocks can stay strong for longer than expected, but this kind of reading often tells beginners not to confuse strength with low-risk entry timing.

What traders may watch next

For traders reviewing PRVA next, the key question is whether the trend still looks healthy or whether price has started to outrun itself. A strong uptrend can stay strong, but entries often become more difficult when price is already extended, so many traders will watch for pullbacks, support reactions, or fresh bases rather than chasing strength blindly.

Company profile

About Privia Health Group, Inc.

Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Parth Mehrotra
Employees
1,226
Market cap
$3.54B
Beta
0.84
52-week range
$18.77 – $28.41
Dividend
No
Exchange
NASDAQ
Country
US
IPO date
28 Apr 2021
ISIN
US74276R1023
CUSIP
74276R102
Company profile data from Financial Modeling Prep. PRVA listed on NASDAQ.
Learn More

Learn the indicators behind this page

Explore More

More stock opportunities

FAQ

Common questions about PRVA

Is this page a buy or sell recommendation?

No. This page is designed to help you review chart structure, momentum and technical context more quickly, but it is not personal financial advice.

Why can a stock look bullish and overbought at the same time?

Strong trending stocks can still become stretched in the short term. That is why trend traders and dip buyers can read the same chart differently.

What should I do next after reading this page?

Open the full dashboard, review the chart in more detail, compare indicators, and decide whether the setup still makes sense within your own process.

PRVA Stock Analysis: Uptrend, above MA50 & MA200, RSI 79 overbought | MyStockHarbor